Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
From LSD to healing minds: Where are we standing in psychedelic drug development? [Labiotech]
March 13, 2024
Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan [Endpoints News]
February 29, 2024
Dr. Joe Tucker, CEO of Enveric Biosciences [The Green Rush]
February 29, 2024
12 Health Care Stocks Moving In Thursday’s Pre-Market Session [Benzinga]
February 29, 2024
EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds [Benzinga]
February 29, 2024
Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments [Benzinga]
February 23, 2024
Enveric sells cannabis patents to focus on psilocin candidates [Green Market Report]
February 23, 2024
Enveric Biosciences Deepens Its Mental Health-Focused Pipeline With Library of Preclinical Compounds [Benzinga]
February 21, 2024
Non-Hallucinogenic Psilocybin-Based Therapies Promote Neuroplasticity Show Promise Treating Mental Health Disorders with Joe Tucker Enveric Biosciences [Empowered Patient Podcast]
February 12, 2024
Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders [ACS Publications]
January 29, 2024
1
2
3
…
9
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
